NB

Nallasamy Balasubramanian

Active Director Managing Director DIN 10553285
DIN 10553285 First appointment Mar 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nallasamy Balasubramanian

Data last updated:

Nallasamy Balasubramanian is a Managing Director at Siruvani Medical Center And Hospitals Private Limited (since 2024).

DIN 10553285
Primary Designation Managing Director
First Appointment 16 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director16 Mar 20242024Active

Board colleagues of Nallasamy Balasubramanian

Directorship timeline

Open interactive timeline →
Siruvani Medical Center And Hospitals Private Limited
Premium access

Shareholding and investment profile for Nallasamy Balasubramanian

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nallasamy Balasubramanian

Nallasamy Balasubramanian currently holds 1 directorship: Siruvani Medical Center And Hospitals Private Limited (Managing Director, since 16 Mar 2024).

Nallasamy Balasubramanian was first appointed on 16 Mar 2024 as Managing Director at Siruvani Medical Center And Hospitals Private Limited.

The current boards of Nallasamy Balasubramanian's companies include Kaliappan Dhanasekar (Siruvani Medical Center And Hospitals Private Limited), Sivakumar Periasamy (Siruvani Medical Center And Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available